Esphera SynBio Revenue and Competitors
Employee Data
- Esphera SynBio has 10 Employees.
- Esphera SynBio grew their employee count by 100% last year.
Esphera SynBio's People
| Name | Title | Email/Phone |
|---|
Esphera SynBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 22 | 29% | N/A | N/A |
#2 | N/A | 9 | 29% | N/A | N/A |
#3 | $0.7M | 9 | -72% | $39.4M | N/A |
#4 | $0.9M | 11 | -83% | $23.8M | N/A |
#5 | $87.6M | 565 | 6% | N/A | N/A |
#6 | $2.8M | 18 | 13% | N/A | N/A |
#7 | $7.8M | 50 | -68% | N/A | N/A |
#8 | $13.5M | 96 | 30% | N/A | N/A |
#9 | $17.8M | 115 | -6% | N/A | N/A |
#10 | $0.9M | 11 | -39% | N/A | N/A |
What Is Esphera SynBio?
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the-shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera's versatile platform shows promise in broader immunomodulation applications.
keywords:N/A
N/A
Total Funding
10
Number of Employees
N/A
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Ottawa
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 10 | -17% | N/A |
#2 | $1M | 10 | 0% | N/A |
#3 | $1.5M | 10 | 0% | N/A |
#4 | $0.9M | 11 | -42% | N/A |
#5 | $1M | 11 | 10% | N/A |